Venrock Healthcare Capital Partners , L.P., Ten Percent Owner at Adverum Biotechnologies, holds 3.75M shares in Tricida (Ticker: TCDA), holds 20.64M shares in VistaGen Therapeutics (Ticker: VTGN), holds 1.54M shares in KalVista Pharmaceuticals (Ticker: KALV). Most recently, Venrock Healthcare Capital Partners , L.P. Sold ― shares of Tricida on Oct 26, 2022 for an estimated value of 3.50M.